These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 4005872
1. Phase II study of rDNA human alpha-2 interferon in multiple myeloma. Wagstaff J, Loynds P, Scarffe JH. Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872 [Abstract] [Full Text] [Related]
2. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase. Case DC, Sonneborn HL, Paul SD, Hiebel J, Boyd MA, Shepp MA, Dorsk BM, Bonnem E. Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870 [Abstract] [Full Text] [Related]
3. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma. Cox EB, Laszlo J, Krown S, Mintzer D, Sarna G. J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554 [Abstract] [Full Text] [Related]
8. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor. Smith DB, Scarffe JH, Wagstaff J, Johnston RJ. Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534 [Abstract] [Full Text] [Related]
9. Treatment of multiple myeloma with recombinant human leukocyte A interferon. Ohno R, Kimura K, Amaki I, Imamura Y, Masaoka T, Miyazaki T, Yoshida Y, Miura Y, Maekawa T, Oguro M. Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317 [Abstract] [Full Text] [Related]
11. Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study. Dutcher JP, Fisher RI, Weiss G, Aronson F, Margolin K, Louie A, Mier J, Caliendo G, Sosman JA, Eckardt JR, Ernest ML, Doroshow J, Atkins M. Cancer J Sci Am; 1997 Dec; 3(3):157-62. PubMed ID: 9161781 [Abstract] [Full Text] [Related]
12. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma. Vugrin D, Hood L, Laszlo J. J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846 [Abstract] [Full Text] [Related]
13. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies]. Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864 [Abstract] [Full Text] [Related]
16. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. Ahre A, Björkholm M, Mellstedt H, Brenning G, Engstedt L, Gahrton G, Gyllenhammar H, Holm G, Johansson B, Järnmark M. Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832 [Abstract] [Full Text] [Related]